vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and WYNDHAM HOTELS & RESORTS, INC. (WH). Click either name above to swap in a different company.

WYNDHAM HOTELS & RESORTS, INC. is the larger business by last-quarter revenue ($334.0M vs $270.8M, roughly 1.2× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -18.0%, a 18.7% gap on every dollar of revenue. On growth, HUTCHMED (China) Ltd posted the faster year-over-year revenue change (-16.5% vs -76.3%). WYNDHAM HOTELS & RESORTS, INC. produced more free cash flow last quarter ($168.0M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Wyndham Hotels & Resorts, Inc., is an American hospitality company based in Parsippany, New Jersey, United States. It describes itself as the largest hotel franchisor in the world, with 9,100 locations.

HCM vs WH — Head-to-Head

Bigger by revenue
WH
WH
1.2× larger
WH
$334.0M
$270.8M
HCM
Growing faster (revenue YoY)
HCM
HCM
+59.7% gap
HCM
-16.5%
-76.3%
WH
Higher net margin
HCM
HCM
18.7% more per $
HCM
0.7%
-18.0%
WH
More free cash flow
WH
WH
$164.6M more FCF
WH
$168.0M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HCM
HCM
WH
WH
Revenue
$270.8M
$334.0M
Net Profit
$2.0M
$-60.0M
Gross Margin
37.7%
Operating Margin
-13.2%
Net Margin
0.7%
-18.0%
Revenue YoY
-16.5%
-76.3%
Net Profit YoY
-83.6%
-170.6%
EPS (diluted)
$0.00
$-0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
WH
WH
Q1 26
$334.0M
Q4 25
$270.8M
$334.0M
Q3 25
$382.0M
Q2 25
$277.7M
$397.0M
Q1 25
$324.5M
$316.0M
Q4 24
$336.0M
Q3 24
$396.0M
Q2 24
$305.7M
$367.0M
Net Profit
HCM
HCM
WH
WH
Q1 26
$-60.0M
Q4 25
$2.0M
$-60.0M
Q3 25
$105.0M
Q2 25
$455.0M
$87.0M
Q1 25
$11.9M
$61.0M
Q4 24
$85.0M
Q3 24
$102.0M
Q2 24
$25.8M
$86.0M
Gross Margin
HCM
HCM
WH
WH
Q1 26
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Operating Margin
HCM
HCM
WH
WH
Q1 26
Q4 25
-13.2%
-11.4%
Q3 25
46.6%
Q2 25
-1.3%
37.8%
Q1 25
-5.0%
35.4%
Q4 24
38.4%
Q3 24
43.2%
Q2 24
-9.0%
39.5%
Net Margin
HCM
HCM
WH
WH
Q1 26
-18.0%
Q4 25
0.7%
-18.0%
Q3 25
27.5%
Q2 25
163.8%
21.9%
Q1 25
3.7%
19.3%
Q4 24
25.3%
Q3 24
25.8%
Q2 24
8.4%
23.4%
EPS (diluted)
HCM
HCM
WH
WH
Q1 26
$-0.80
Q4 25
$0.00
$-0.77
Q3 25
$1.36
Q2 25
$0.52
$1.13
Q1 25
$0.01
$0.78
Q4 24
$1.06
Q3 24
$1.29
Q2 24
$0.03
$1.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
WH
WH
Cash + ST InvestmentsLiquidity on hand
$1.4B
$64.0M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$468.0M
Total Assets
$1.8B
$4.2B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
WH
WH
Q1 26
$64.0M
Q4 25
$1.4B
$64.0M
Q3 25
$70.0M
Q2 25
$1.4B
$50.0M
Q1 25
$836.1M
$48.0M
Q4 24
$103.0M
Q3 24
$72.0M
Q2 24
$802.5M
$70.0M
Total Debt
HCM
HCM
WH
WH
Q1 26
Q4 25
$93.2M
$2.5B
Q3 25
$2.6B
Q2 25
$93.4M
$2.5B
Q1 25
$82.8M
$2.5B
Q4 24
$2.4B
Q3 24
$2.4B
Q2 24
$82.1M
$2.4B
Stockholders' Equity
HCM
HCM
WH
WH
Q1 26
$468.0M
Q4 25
$1.2B
$468.0M
Q3 25
$583.0M
Q2 25
$1.2B
$570.0M
Q1 25
$759.9M
$579.0M
Q4 24
$650.0M
Q3 24
$583.0M
Q2 24
$740.1M
$623.0M
Total Assets
HCM
HCM
WH
WH
Q1 26
$4.2B
Q4 25
$1.8B
$4.2B
Q3 25
$4.3B
Q2 25
$1.8B
$4.3B
Q1 25
$1.3B
$4.2B
Q4 24
$4.2B
Q3 24
$4.2B
Q2 24
$1.3B
$4.2B
Debt / Equity
HCM
HCM
WH
WH
Q1 26
Q4 25
0.08×
5.37×
Q3 25
4.43×
Q2 25
0.08×
4.44×
Q1 25
0.11×
4.29×
Q4 24
3.72×
Q3 24
4.19×
Q2 24
0.11×
3.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
WH
WH
Operating Cash FlowLast quarter
$8.2M
$367.0M
Free Cash FlowOCF − Capex
$3.4M
$168.0M
FCF MarginFCF / Revenue
1.2%
50.3%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$437.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
WH
WH
Q1 26
$367.0M
Q4 25
$8.2M
$152.0M
Q3 25
$86.0M
Q2 25
$-72.9M
$70.0M
Q1 25
$40.3M
$59.0M
Q4 24
$134.0M
Q3 24
$79.0M
Q2 24
$-39.8M
$1.0M
Free Cash Flow
HCM
HCM
WH
WH
Q1 26
$168.0M
Q4 25
$3.4M
$136.0M
Q3 25
$75.0M
Q2 25
$-82.2M
$58.0M
Q1 25
$32.5M
$52.0M
Q4 24
$109.0M
Q3 24
$71.0M
Q2 24
$-49.9M
$-6.0M
FCF Margin
HCM
HCM
WH
WH
Q1 26
50.3%
Q4 25
1.2%
40.7%
Q3 25
19.6%
Q2 25
-29.6%
14.6%
Q1 25
10.0%
16.5%
Q4 24
32.4%
Q3 24
17.9%
Q2 24
-16.3%
-1.6%
Capex Intensity
HCM
HCM
WH
WH
Q1 26
Q4 25
1.8%
4.8%
Q3 25
2.9%
Q2 25
3.3%
3.0%
Q1 25
2.4%
2.2%
Q4 24
7.4%
Q3 24
2.0%
Q2 24
3.3%
1.9%
Cash Conversion
HCM
HCM
WH
WH
Q1 26
Q4 25
4.21×
Q3 25
0.82×
Q2 25
-0.16×
0.80×
Q1 25
3.38×
0.97×
Q4 24
1.58×
Q3 24
0.77×
Q2 24
-1.54×
0.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

WH
WH

Fee-related and other revenues$334.0M100%
Management and other fees$2.0M1%

Related Comparisons